Search Results

Waters and Princeton University signed a multi-year agreement to take on real-world challenges in biologics and materials research.

PacBio announced the appointment of Olga Troyanskaya, Ph.D., Professor of Computer Science and the Lewis Sigler Institute for Integrative Genomics at Princeton University to PacBio’s Scientific Advisory Board and Jay Shendure, Ph.D. as Chair.

C2Sense, Inc., experts in advanced optical sensing platforms and Princeton BioMeditech Corporation, a world leader in rapid, point-of-care diagnostics, announced that they have secured a second National Institutes of Health Rapid Acceleration of Diagnostics Tech High Performance award.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical theranostics company, announced that the company has opened its U.S. headquarters in Princeton, New Jersey and appointed Roger Estafanos as U.S. General Manager.

CytoSorbents Corporation announced that it has received ISO 13485 Certification of its new manufacturing facility in Princeton, New Jersey from its European Union notified body, clearing the way for full manufacturing of CytoSorb®, DrugSorb®-ATR, and ECOS-300CY® from this site, with capacity to add additional product lines as they are developed.

[20-June-2024] KAN-003 seeks to improve outcomes for patients with ICI-naive cancers and is undergoing preclinical studies in collaboration with the MD Anderson Cancer Center. PRINCETON, N.J. , June 20, 2024 /PRNewswire/ -- Kanvas Biosciences , a full-stack spatial biology company, today introduced its newest drug candidate in its Immuno-oncology Program: KAN-003. The Kanvas platform

Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.